A Phase ??? Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Single Injection Adductor Canal Block With HR18034 for Postoperative Pain Management in Total Knee Arthroplasty
Latest Information Update: 04 Nov 2024
Price :
$35 *
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Shanghai Hengrui Pharmaceutical
- 30 Oct 2024 Status changed from recruiting to discontinued.
- 05 Sep 2024 Status changed from not yet recruiting to recruiting.
- 24 Jul 2024 New trial record